HSBC Holdings’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,654
Closed -$276K 3233
2025
Q4
$276K Sell
8,654
-17,384
-67% -$542K ﹤0.01% 2560
2025
Q3
$714K Buy
26,038
+4,090
+19% +$124K ﹤0.01% 1940
2025
Q2
$802K Buy
21,948
+16,125
+277% +$557K ﹤0.01% 1907
2025
Q1
$228K Buy
+5,823
New +$262K ﹤0.01% 2547
2024
Q2
Sell
-7,481
Closed -$257K 3173
2024
Q1
$257K Buy
+7,481
New +$270K ﹤0.01% 2543
2023
Q3
Sell
-11,076
Closed -$228K 2857
2023
Q2
$228K Sell
11,076
-4,183
-27% -$62.7K ﹤0.01% 2269
2023
Q1
$233K Buy
15,259
+5,862
+62% +$129K ﹤0.01% 2331
2022
Q4
$217K Buy
+9,397
New +$272K ﹤0.01% 2734
2021
Q3
Sell
-2,447
Closed -$326K 3175
2021
Q2
$326K Buy
+2,447
New +$284K ﹤0.01% 2458
2021
Q1
Sell
-2,935
Closed -$414K 3139
2020
Q4
$414K Buy
+2,935
New +$326K ﹤0.01% 2325

Other funds holding TWST

HSBC Holdings's TWST Position: Q1 2026 in Review

HSBC Holdings sold out of Twist Bioscience (TWST) in Q1 2026, closing a stake of 8,654 shares — an estimated $276K sold.

HSBC Holdings first reported a position in TWST in Q4 2020 and held it in 10 quarters. The position peaked at $802K in Q2 2025. 280 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • HSBC Holdings reported no remaining Twist Bioscience position as of Q1 2026 after selling out during the quarter.
  • HSBC Holdings sold 8,654 Twist Bioscience shares in Q1 2026, an estimated $276K.
  • HSBC Holdings first reported a position in Twist Bioscience in Q4 2020 and held it in 10 quarters.
  • HSBC Holdings's Twist Bioscience position peaked at $802K in Q2 2025.
  • 280 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.